IDEXX Laboratories Inc. (IDXX)

252.72
2.00 0.79
NASDAQ : Health Technology
Prev Close 254.74
Open 253.58
Day Low/High 251.60 / 256.25
52 Wk Low/High 176.11 / 294.57
Volume 345.36K
Avg Volume 395.90K
Exchange NASDAQ
Shares Outstanding 85.78M
Market Cap 22.57B
EPS 4.30
P/E Ratio 54.59
Div & Yield N.A. (N.A)

Latest News

Forget About the Fed: Cramer's 'Mad Money' Recap (Wednesday 10/30/19)

Forget About the Fed: Cramer's 'Mad Money' Recap (Wednesday 10/30/19)

Jim Cramer says not having enough time, and having too much government regulation, have more impact on the future revenue streams of companies than does the Federal Reserve.

Marvell Technology, Cedar Fair, Square: 'Mad Money' Lightning Round

Marvell Technology, Cedar Fair, Square: 'Mad Money' Lightning Round

Jim Cramer weighs in on Marvell Technology, Cedar Fair, Square, MGM Resorts, Idexx Laboratories, and more.

IDEXX Laboratories Announces Leadership Changes

IDEXX Laboratories Announces Leadership Changes

Jay Mazelsky Appointed President and Chief Executive Officer and Elected to IDEXX Board

IDEXX Laboratories To Release 2019 Third Quarter Financial Results

IDEXX Laboratories To Release 2019 Third Quarter Financial Results

WESTBROOK, Maine, Oct. 10, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc.

IDEXX Breakthrough Kidney Function Test Now Key Component Of IRIS Staging Guidelines

IDEXX Breakthrough Kidney Function Test Now Key Component Of IRIS Staging Guidelines

New guidelines enhance the ability of veterinarians to assess renal function  WESTBROOK, Maine, Oct.

Chewy Tumbles on Earnings - Here's When to Take a Bite

Chewy Tumbles on Earnings - Here's When to Take a Bite

Chewy stock is falling on earnings, despite reporting strong growth. Here's how to trade CHWY stock now.

These 2 Companies Could Be More Than Pet Projects for Investors

These 2 Companies Could Be More Than Pet Projects for Investors

IDEXX Laboratories and Zoetis Inc. appear ready to trade higher, offering stable opportunities as the dog-eat-dog trade war lingers on.

Let's Make a Deal: Cramer's 'Mad Money' Recap (Monday 8/26/19)

Let's Make a Deal: Cramer's 'Mad Money' Recap (Monday 8/26/19)

Jim Cramer says a quick trade deal is unlikely, and investors need to filter out the day-to-day noise.

IDEXX Laboratories To Host 2019 Investor Day

IDEXX Laboratories To Host 2019 Investor Day

WESTBROOK, Maine, Aug. 6, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc.

IDEXX Laboratories Announces Second Quarter Results

IDEXX Laboratories Announces Second Quarter Results

WESTBROOK, Maine, Aug. 1, 2019 /PRNewswire/ -- Reports revenue growth of 7% on a reported basis and 9% on an organic basis, driven by Companion Animal Group ("CAG") Diagnostics recurring revenue growth of 9% reported and 11% organic Delivers EPS of $1.

IDEXX Laboratories Elects Sam Samad To Board Of Directors

IDEXX Laboratories Elects Sam Samad To Board Of Directors

WESTBROOK, Maine, July 18, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, announced today the election of Sam Samad, the Senior Vice...

A Tale of Two Economies: Cramer's 'Mad Money' Recap (Wednesday 7/17/19)

A Tale of Two Economies: Cramer's 'Mad Money' Recap (Wednesday 7/17/19)

Jim Cramer says the consumer economy is in great shape, but the business economy is a different story. He wants the Fed to pay attention.

Waste Management, Idexx Laboratories and more: 'Mad Money' Lightning Round

Waste Management, Idexx Laboratories and more: 'Mad Money' Lightning Round

Jim Cramer weighs in on Waste Management, Idexx Laboratories, TriplePoint Venture Growth, Cato Corp., Paycom Software, New Residential Investment and more.

IDEXX Laboratories To Release 2019 Second Quarter Financial Results

IDEXX Laboratories To Release 2019 Second Quarter Financial Results

WESTBROOK, Maine, July 15, 2019 /PRNewswire/ --  IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled the release of its 2019 second quarter...

IDEXX Laboratories Chairman, President And Chief Executive Officer, Jonathan Ayers, Taking Medical Leave Of Absence

IDEXX Laboratories Chairman, President And Chief Executive Officer, Jonathan Ayers, Taking Medical Leave Of Absence

Jay Mazelsky, Executive Vice President, Companion Animal Group, Appointed Interim President and Chief Executive Officer

How Much China?: Cramer's 'Mad Money' Recap (Wednesday 5/22/19)

How Much China?: Cramer's 'Mad Money' Recap (Wednesday 5/22/19)

This market can be judged on how much exposure a stock has to China and trade war risks. Jim Cramer starts with Apple.

IDEXX Laboratories To Present At Two Upcoming Institutional Investor Conferences

IDEXX Laboratories To Present At Two Upcoming Institutional Investor Conferences

WESTBROOK, Maine, May 20, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, will participate in two upcoming conferences: Wednesday, May...

Wheaton Precious Metals, PetMed Express: 'Mad Money' Lightning Round

Wheaton Precious Metals, PetMed Express: 'Mad Money' Lightning Round

Jim Cramer takes a look at Wheaton Precious Metals, Cirrus Logic, PetMed Express, Knight Transportation, Chart Industries and more.

What to Watch Out For: Cramer's 'Mad Money' Recap (Thursday 5/2/19)

What to Watch Out For: Cramer's 'Mad Money' Recap (Thursday 5/2/19)

Jim Cramer says that although a sell-off can breed a buying opportunity, investors need to worry about sky-high IPOs and other signs of froth.

The New #38 Most Shorted Nasdaq 100 Component: Idexx Laboratories

The New #38 Most Shorted Nasdaq 100 Component: Idexx Laboratories

The most recent short interest data has been released for the 03/29/2019 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Short-Squeezed Ugly Ducklings: Cramer's 'Mad Money' Recap (Wednesday 2/6/19)

Short-Squeezed Ugly Ducklings: Cramer's 'Mad Money' Recap (Wednesday 2/6/19)

Jim Cramer says Wednesday brought multiple positive earnings surprises that prompt us to ask how is it possible that these moves can occur without warning?

Canada Goose, Wix.com, Yext: 'Mad Money' Lightning Round

Canada Goose, Wix.com, Yext: 'Mad Money' Lightning Round

Jim Cramer weighs in on Canada Goose, Wix.com, Yext, Idexx Laboratories, Yeti, Clean Harbors, Nio and more.

Watch Out for the Wave: Cramer's 'Mad Money' Recap (Tuesday 1/29/19)

Watch Out for the Wave: Cramer's 'Mad Money' Recap (Tuesday 1/29/19)

Jim Cramer says that if expectations are too high, even a great quarter cannot save you from the wave of selling.

Carvana, Bank OZK, Idexx Labs: 'Mad Money' Lightning Round

Carvana, Bank OZK, Idexx Labs: 'Mad Money' Lightning Round

Jim Cramer takes a look at Carvana, Bank OZK, Idexx Labs, Patterson-UTI Energy, 3D Systems, AbbVie and more.

Starbucks, Square, Alibaba: 'Mad Money' Lightning Round

Starbucks, Square, Alibaba: 'Mad Money' Lightning Round

Jim Cramer weighs in on Starbucks, Square, Alibaba, ArcelorMittal, Dynavax Technologies, Aimmune Therapeutics, Clearway Energy and more.

Breaking Down Citigroup Earnings: Cramer's 'Mad Money' Recap (Monday 1/14/19)

Breaking Down Citigroup Earnings: Cramer's 'Mad Money' Recap (Monday 1/14/19)

We may be so worried about the state of the global economy that we're missing some great opportunities, Jim Cramer says.

The Fed Should Wait and See: Cramer's 'Mad Money' Recap (Thursday 12/13/18)

The Fed Should Wait and See: Cramer's 'Mad Money' Recap (Thursday 12/13/18)

Conflicting data about the economy should give the Federal Reserve pause.

Idexx Laboratories Becomes #45 Most Shorted Nasdaq 100 Component, Replacing Vertex Pharmaceuticals

Idexx Laboratories Becomes #45 Most Shorted Nasdaq 100 Component, Replacing Vertex Pharmaceuticals

The most recent short interest data has been released for the 11/30/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

TheStreet Quant Rating: B (Buy)